Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by transforming growth factor beta in experimental colitis

被引：0
|
作者：
Colucci, R. [1 ]
Ippolito, C.
Antonioli, L. [1 ]
Mattii, L.
Fornai, M. [1 ]
Blandizzi, C. [1 ]
Bernardini, N. [2 ]
机构：
[1] Univ Pisa, Dept Internal Med, Div Pharmacol, I-56100 Pisa, Italy
[2] Univ Pisa, Dept Human Morphol, Div Pharmacol, I-56100 Pisa, Italy
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2012年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [31] Role of endothelial transforming growth factor-beta signalling for chronic fibrotic remodelling in murine and human venous thrombosis
    Bochenek, M. L.
    Leidinger, C.
    Rosinus, N. S.
    Lankeit, M.
    Mayer, E.
    Muenzel, T.
    Konstantinides, S.
    Bosmann, M.
    Schaefer, K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 545 - 545
  • [32] Endothelin-1 and transforming growth factor-β1 induce a pro-fibrotic phenotype in cultured human dermal microvascular endothelial cells
    Soldano, Stefano
    Montagna, Paola
    Brizzolara, Renata
    Contini, Paola
    Sulli, Alberto
    Cutolo, Maurizio
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S12 - S12
  • [33] TRANSFORMING GROWTH-FACTOR-BETA GENE-THERAPY AMELIORATES EXPERIMENTAL COLITIS IN RATS
    GILADI, E
    RAZ, E
    KARMELI, F
    OKON, E
    RACHMILEWITZ, D
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1995, 7 (04) : 341 - 347
  • [34] PROTEASE INHIBITORS INTERFERE WITH THE TRANSFORMING GROWTH FACTOR-BETA-DEPENDENT BUT NOT THE TRANSFORMING GROWTH FACTOR-BETA-INDEPENDENT PATHWAY OF TUMOR CELL-MEDIATED IMMUNOSUPPRESSION
    HUBER, D
    PHILIPP, J
    FONTANA, A
    JOURNAL OF IMMUNOLOGY, 1992, 148 (01): : 277 - 284
  • [35] Pharmacological Inhibitors of Integrin αvβ6 That Differentially Modulate Protein Conformation Are Similarly Effective at Inhibiting Transforming Growth Factor Beta (TGF-β) Signaling in the Fibrotic Lung
    Budi, E.
    Kotak, P.
    Ho, S.
    Rao, V.
    Chen, C.
    Wolters, P.
    Schaub, J.
    Turner, S.
    Decaris, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [36] Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression
    Dolivo, David M.
    Larson, Sara A.
    Dominko, Tanja
    CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 38 : 49 - 58
  • [37] Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
    Riching, Andrew S.
    Zhao, Yuanbiao
    Cao, Yingqiong
    Londono, Pilar
    Xu, Hongyan
    Song, Kunhua
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (136):
  • [38] Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma
    Birch, Joanna L.
    Coull, Barry J.
    Spender, Lindsay C.
    Watt, Courtney
    Willison, Alice
    Syed, Nelofer
    Chalmers, Anthony J.
    Hossain-Ibrahim, M. Kismet
    Inman, Gareth J.
    CELLULAR SIGNALLING, 2020, 72
  • [39] The role of transforming growth factor beta signalling pathways in tumour biology
    Landstrom, Marene
    TOXICOLOGY LETTERS, 2012, 211 : S4 - S4
  • [40] Identification of peptide inhibitors of transforming growth factor beta 1
    Dotor, J
    Lopez, AB
    Lasarte, JJ
    Riezu, JI
    Prieto, J
    Borras-Cuesta, F
    JOURNAL OF HEPATOLOGY, 2004, 40 : 30 - 30
12345